Publications in collaboration with researchers from Hospital Universitario La Fe (12)

2023

  1. Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

    Transplantation Reviews, Vol. 37, Núm. 1

  2. Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  3. Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  2. Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients

    Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1847-1855

2021

  1. There Are 33,784 Functioning Kidney Grafts in Spain: Who Monitors Them and How?

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2672-2674

2020

  1. Use of tocilizumab in kidney transplant recipients with COVID-19

    American Journal of Transplantation, Vol. 20, Núm. 11, pp. 3182-3190

2019

  1. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study

    Transplant International, Vol. 32, Núm. 3, pp. 313-322

  2. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

2015

  1. Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus

    Transplantation Direct, Vol. 1, Núm. 7, pp. E24

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2007

  1. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159